Oracle Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.48M Sell
354,338
-351,078
-50% -$2.75M 1.48% 11
2025
Q3
$5.45M Buy
705,416
+324,416
+85% +$2.53M 3.41% 5
2025
Q2
$3.32M Sell
381,000
-184,900
-33% -$1.34M 2.28% 10
2025
Q1
$4.5M Buy
+565,900
New +$5.72M 2.27% 8
2024
Q1
Sell
-112,861
Closed -$2.43M 31
2023
Q4
$2.43M Buy
+112,861
New +$2.08M 1.48% 17

Other funds holding TDOC

Oracle Investment Management's TDOC Position: Q4 2025 in Review

Oracle Investment Management reduced its Teladoc Health (TDOC) stake by 50% in Q4 2025, selling an estimated $2.75M and leaving 354,338 shares worth $2.48M. The position accounts for 1.48% of the portfolio, ranked #11.

Oracle Investment Management first reported a position in TDOC in Q4 2023 and has held it in 5 quarters since. The position peaked at $5.45M in Q3 2025. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Oracle Investment Management held 354,338 shares of Teladoc Health worth $2.48M as of Q4 2025.
  • Oracle Investment Management sold 351,078 Teladoc Health shares in Q4 2025, an estimated $2.75M.
  • Teladoc Health made up 1.48% of Oracle Investment Management's portfolio in Q4 2025, its #11 holding.
  • Oracle Investment Management first reported a position in Teladoc Health in Q4 2023 and has held it in 5 quarters since.
  • Oracle Investment Management's Teladoc Health position peaked at $5.45M in Q3 2025.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.